20-F/A XBRL

AMENDMENT NO. 1 TO FORM 20-F

Company: China SXT Pharmaceuticals, Inc.
Filed: May 19, 2023
Period of Report: March 31, 2022
Accession Number: 0001213900-23-041596

View Document ↗ View on SEC.gov ↗